Antimicrobial resistance (AMR) poses a significant public health threat. This global health concern emerges when microorganisms such as bacteria, viruses, fungi, or parasites develop resistance against antimicrobial agents meant to eradicate them. The issue has magnified to a point that it remains largely unacknowledged despite its increasing severity.
In fact, a recent report published in Lancet illustrates that bacterial AMR resulted in nearly 5 million deaths worldwide in 2019 alone. If not addressed effectively, this figure could potentially scale up to 10 million annual deaths by 2050. It’s important to note that while the development of resistance is natural, practices such as misuse of antimicrobial medicines and poor infection control exacerbate the crisis.
Furthermore, the absence of a strategic response and the shortfall in the implementation of robust AMR surveillance systems catalyze the spread and intensification of AMR. Misconceptions around the necessity of antibiotics for all types of infections fuel the inappropriate utilization and consequently, development of resistance. Historical observation suggests that resistance to various antimicrobials, including sulphonamides and penicillin, has been a decades-old phenomenon.
Almost all infectious diseases deemed as significant public health concerns are now challenged by AMR. Infections associated with high resistance bacteria like methicillin-resistant staphylococcus aureus (MRSA) or multi-drug resistant gram-negative bacteria are increasingly prevalent in healthcare settings. Alarmingly, evidence shows that death rates for patients with such resistant infections are almost twice as high as those with non-resistant bacterial infections.
As the healthcare industry reckons with the implications of AMR, it must also confront the challenges it poses to primary healthcare systems, particularly in rural areas that rely on primary health services. If AMR is left unmitigated, the entire primary healthcare infrastructure, heavily reliant on first-generation drugs, could potentially collapse. Addressing these challenges necessitates global collective action. While steps are underway with organizations like the World Health Organization (WHO) drafting action plans, commitment from all stakeholders is essential.
Measures may include educating patients, medical professionals, and pharmacists; strengthening and better implementing existing infection control programs; revising pharmaceutical companies’ activities; regulating the use of antimicrobials in agriculture, livestock, and human treatments; and fostering collaboration between industry, government bodies, and academia in the quest for new drugs and vaccines.
Regulatory measures against unauthorized sales of antimicrobials, continuous medical education on AMR, and establishment of a nationwide hospital-based sentinel surveillance system for resistance monitoring are all vital steps towards mitigating AMR. Uniform treatment guidelines and public health measures including improved hygiene practices, widespread immunization, and rapid outbreak response can substantially reduce reliance on antimicrobials.
The daunting task of tackling AMR requires a multi-pronged approach centered around accepting the gravity of AMR, investing in infrastructure, and taking coordinated action. Ultimately, it will take a global collective effort and a fundamental shift in mindset towards responsible antibiotic use to limit the spread of resistant microbes and safeguard our healthcare systems from this overlooked epidemic.
Source: https://kashmirobserver.net/2024/09/02/epidemic-of-antimicrobial-resistance-amr-and-way-forward/